Good guy in bad company: How STRNs convert PP2A into an oncoprotein




Kurppa Kari J, Westermarck Jukka

2020

Cancer Cell

38

1

20

22

4

1535-6108

1878-3686

DOIhttps://doi.org/10.1016/j.ccell.2020.06.011

https://research.utu.fi/converis/portal/detail/Publication/48901298



Certain Protein Phosphatase 2A (PP2A) complexes are human tumor suppressors. In contrast, a paper in this issue of Cancer Cell and two other recent studies demonstrate that PP2A-STRN3/4 complexes inactivate Hippo tumor suppressor pathway, resulting in YAP activation and tumorigenesis. Furthermore, this new oncogenic phosphatase mechanism may be druggable


Last updated on 2024-26-11 at 23:23